BioMed Research International

BioMed Research International / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 850802 |

Xiu-Ju Zhao, Hexian Zhuo, "ECR-MAPK Regulation in Liver Early Development", BioMed Research International, vol. 2014, Article ID 850802, 9 pages, 2014.

ECR-MAPK Regulation in Liver Early Development

Academic Editor: Klaus Wimmers
Received06 Jun 2014
Revised27 Aug 2014
Accepted16 Sep 2014
Published18 Dec 2014


Early growth is connected to a key link between embryonic development and aging. In this paper, liver gene expression profiles were assayed at postnatal day 22 and week 16 of age. Meanwhile another independent animal experiment and cell culture were carried out for validation. Significance analysis of microarrays, qPCR verification, drug induction/inhibition assays, and metabonomics indicated that alpha-2u globulin (extracellular region)-socs2 (-SH2-containing signals/receptor tyrosine kinases)-ppp2r2a/pik3c3 (MAPK signaling)-hsd3b5/cav2 (metabolism/organization) plays a vital role in early development. Taken together, early development of male rats is ECR and MAPK-mediated coordination of cancer-like growth and negative regulations. Our data represent the first comprehensive description of early individual development, which could be a valuable basis for understanding the functioning of the gene interaction network of infant development.

1. Introduction

Development is differential expression of the genome of organisms in different time points. Mammalian liver especially plays a vital role in the coordination of various physiological processes, and due to the different metabolic needs for male and female reproduction, mammalian liver shows considerable sexual dimorphism; this phenotypic expression is mediated via sex hormones [1]. Androgen response of the rat liver shows notable change during individual development and only the postpubertal adult (40–750 days of age) is subject to androgen-inducible genes and androgen-repressible genes [2]. Thus, transcriptional control in mammals must be properly coregulated for early stages of liver formation, perinatal repression, and position-dependent regulation [3]. Furthermore, expression profiles of fetal and natal liver tissues from mice reveal two stages during embryonic liver development; embryonic day 14.5 is a transition point when hepatocytes occur. Postnatal processes are also divided into two stages (ΙΙΙ and ΙV) and genes expression profile of stage ΙV (ranging from day 7 to week 18) exhibited more invariant property [4].

Previous researches focus on embryonic development, using targeted methods such as genetic modification, quantitative PCR, hybridization, and electrophoresis. However, early growth is less concerned. Early growth consists of natal, prepuberty, puberty, and adult stages. And moreover, early growth is connected to a key link between embryonic development and aging [4]. Therefore it is necessary to deepen the study of the early development of individual growth and thus to provide a basis and reference for dietary intake and disease prevention and control in the process of human growth, especially infant.

Utilizing systems biology approaches, for example, by combining global gene expression profiling and metabolic pattern techniques, provides means to determine characteristic transcript profile and endpoint metabolic effects of development. Integrated information from transcriptomic and metabonomic profiling contributes to elucidate mechanisms of a developmental effect in detail and with comprehensiveness.

This research compared the gene expression profiles of 22 days (3 weeks) and 16 weeks of age, using Wistar rat as a model from public database, and furthermore clinical biochemistry, qPCR, cell culture, and NMR were carried out for validation and confirmation from independent animal experiment, to reveal temporal migration information and the transcription pattern of this early growth process.

2. Materials and Methods

2.1. Animal Experiment and Cell Culture

This study partially came from public database GSE32156 [5]. Briefly, offspring from Wistar Han dams were fed normally. Liver samples were collected at postnatal day (PND) 22 () and week 16 () of age for liver gene expression profile analysis. Independent animal experiment was carried out according to guidelines of the government of China. Sera for clinical biochemistry, urines for NMR, and livers for qPCR and cell culture were collected when the rats were decapitated after anesthesia with isoflurane. Rat primary liver cells were cultured and dexamethasone (dex, 0.1 μM) or cycloheximide (CHX, 0.05 μg/mL) was added as indicated.

2.2. Clinical Biochemistry

Sera were analyzed for glucose (Glc), total cholesterol (CHOL), creatinine (CREA), triglyceride (TG), albumin (ALB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (AlkP), total protein (TP), and testosterone using biochemical analyzer and radioimmunoassay.

2.3. Transcriptomic Analysis

Total RNA was isolated from 10 rat livers, 5 from the control pups and 5 from the adults, with Trizol Reagent (Invitrogen Corp., Carlsbad, CA), in accordance with the manufacturer’s instructions. The concentration and purity of total RNA were determined by spectrophotometer, 28S and 18S rRNA. The Affymetrix Rat Genome 230 2.0 arrays were used to monitor variations in gene expression profile. The log-transformed (base = 2) data were obtained for all probes and array-wise normalized using Affymetrix Dchip 2006.

The t-test and Wilcoxon signed-rank test were utilized for significance analysis of microarrays (SAM) [69]. A permutation test was employed for estimating the false-discovery rate (FDR < 0.05, ~500). The CapitalBio Molecule Annotation System (MAS), KEGG, and GenMAPP databases were used for pathway analysis ( For each pathway, genes with known rat orthologues were compared with sets of significant genes from SAM to define the effects of corresponding pathway.

The relationship of genes or gene clusters was carried out using Pearson’s correlation, Spearman’s correlation, or 2D STOCSY (statistical total correlation spectroscopy).

2.4. Quantitative Real-Time PCR and Western Blot

cDNA was synthesized using an oligo-(dT)15 primer (Invitrogen). PCR primers were designed with Primer Premier 5.0 software. The housekeeping geneβ-actin was used as an internal control. The PCR amplification was conducted at 95°C for 15 min, followed by 40 cycles of 94°C for 5 s, 58°C for 15 s, and 72°C for 10 s. The relative mRNA levels of selected genes were calculated with the method [10]. Liver proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to blotting membrane. Immunoblots were blocked with 3% bovine serum albumin in Tris-buffered saline/Tween-20 buffer for 60 min at room temperature and incubated overnight at 4°C with primary antibodies. Blots were developed by an Enhanced Chemiluminescence Western blotting kit (Amersham Biosciences, Uppsala, Sweden) and visualized by a Gene Genome bioimaging system. Bands were analyzed by densitometry with GeneTools software (Syngene, Frederick, MD, USA). Values were reported as means ± SD. Statistical differences were determined by the one-way ANOVA multiple range test and the Wilcoxon rank sum test. Statistical significance was set at .

2.5. NMR Spectroscopy Acquirement

550 μL urine was mixed with 55 μL of phosphate buffer, followed by centrifugation. 1D 1H NMR spectra were acquired (298 K, Bruker Avance III-600 MHz NMR spectrometer) with 32 transients for urine using a standard presaturation pulse sequence (presaturation during a relaxation delay and during the mixing time). 2D J-resolved, 1H-1H correlation, total 1H-1H correlation, 1H-13C heteronuclear single quantum coherence, and 1H-13C heteronuclear multiple bonds correlation NMR spectra [1113] were acquired for selected urine to assign metabolites.

2.6. Statistical Analysis of NMR Spectra

NMR spectra were processed routinely [14] for phase, baseline, and chemical shift reference calibrations.

Unsupervised PCA (principal component analysis) was performed (SIMCA-P 11.0 demo, Umetrics, Sweden) to outline intrinsic similarity/dissimilarity within the data set scaled to unit variance (UV). Comparisons between temporal animals were made by carrying out qualitative PLS (partial least square regression) and O-PLS (orthogonal projection to latent structures) models (class information as qualitative Y variable). The validity of the models was assessed by (predictability) and (interpretability) of the model. Meanwhile, the same models were validated by a 7-fold cross validation [15], cross validation-ANOVA [1618], and a permutation test () [19]. Valid models including significantly changed metabolites (denoted by red color) were visualized and shown in the colored correlation coefficient loading plots (MATLAB version 7.1, Mathworks Inc; Natwick, USA).

3. Results

3.1. Weight and Clinical Biochemistry of Early Individual Development

Adult rats (~313.6 g) have much more weight than pups (~219.3 g) (, Table 1). Serum clinical biochemistry data from the adult rats contained higher levels of metabolites, such as glucose, triglyceride, testosterone, and lower enzymes, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (AlkP) compared with those from the pup rats (, Table 1).


Body mass, g
AlkP, IU/L
Glc, mmol/L
TG, mmol/L
Testosterone, ng/mL

3.2. Coexpressing Genes of Early Individual Development

Coexpressing genes between adults and pups belong to REDOXIDATION [ATP binding, electron carrier activity, oxoglutarate dehydrogenase (succinyl-transferring) activity, L-2-hydroxyglutarate dehydrogenase], PROTEIN TRANSLATION, TRANSLOCATION AND PROTEOLYSIS [ADP-ribosylation factor binding, glutamyl-tRNA aminoacylation, proteolysis, protein tyrosine phosphatase activity, SMAD protein nuclear translocation], TRANSCRIPTION REGULATION [ADP-ribose diphosphatase nucleotide and nucleic acid metabolic process, 3′ pre-RNA cleavage], CELL CYCLE [nucleotide-excision repair (cyclin-dependent protein serine/threonine kinase activity), positive regulation of cell proliferation], and SYSTEM ORGANIZATION [acrosome intracellular phorbol ester receptor signaling cascade, nervous system development, motor axon guidance, neurotransmitter acetylcholine receptor activity, G protein coupled olfactory receptor protein signaling pathway, detection of chemical stimulus involved in sensory perception of bitter taste, keratin filament, regulation of the force of heart contraction, regulation of hindgut contraction] (Supplementary Table 1,   , 0.9999 ≦ change fold ≦ 1.0001) (see Supplementary Table 1 in Supplementary Material available online at

3.3. Differential Genes of Early Individual Development

The differential genes between adults and pups were listed (Table 2), of which 48 genes/probe sets were upregulated (, fold > 1.53) and 30 genes were downregulated (, fold < 0.665). According to GO terms [20], these BIOLOGICAL PROCESSES were transport, C21-steroid hormone biosynthetic process, metabolic process, oxidation reduction, estrogen metabolic process, digestion, cell morphogenesis, oxygen and reactive oxygen species metabolic process, superoxide metabolic process, transcription, cell proliferation, cell differentiation, protein amino acid dephosphorylation, regulation of cell growth, cell adhesion, immune response, and proteolysis; CELL COMPONENTS were extracellular region and space, mitochondrion, endoplasmic reticulum, peroxisome, integral to membrane, protein phosphatase type 2A complex, plasma membrane, and Golgi-associated vesicle; MOLECULAR FUNCTIONS were transporter activity, catalytic activity, 3-beta-hydroxy-delta-5-steroid dehydrogenase activity, monooxygenase activity, endopeptidase inhibitor activity, estrone sulfotransferase activity, estradiol 17-beta-dehydrogenase activity, identical protein binding, glucuronosyltransferase activity, superoxide-generating NADPH oxidase activity, nucleic acid binding, methyltransferase activity, protein binding, protein tyrosine/serine/threonine phosphatase activity, oxidoreductase activity, protein phosphatase type 2A regulator activity, growth hormone receptor binding, proton-dependent oligopeptide secondary active transmembrane transporter activity, metalloendopeptidase activity, sterol/transporter activity, asparagine synthase (glutamine-hydrolyzing) activity, cytokine activity, transferase activity (transferring acyl groups other than aminoacyl groups), aldo-keto reductase activity, and so forth.

Public IDGene symbolFold

AB039825obp3 3.75
J00738obp3 3.45
AF368860loc680367 /// loc680406 /// rup2 3.40
AF198441rup2 3.26
NM_012584hsd3b5 3.14
BI288203dhrs7 3.05
AF368860loc680367 /// rup2 3.02
J02861cyp2c13 2.93
AA893518loc680367 2.87
AB039826loc259245 /// loc259246 /// mup5 2.68
U46118cyp3a9 2.52
AB039823loc259246 2.51
NM_012693cyp2a2 2.45
NM_032082hao2 2.36
NM_012883sult1e1 2.34
NM_134380ust5r 2.20
AI072107akr1c1 2.16
AB039828mup5 2.10
BM385735stac3 2.07
NM_019184cyp2c29 1.96
NM_053524nox4 1.88
AF072439zfp37 1.75
AI232716inmt 1.71
BM390462rgd1310209 1.68
AI454016lrtm2 1.66
BE110108dusp1 1.66
AA866264rgd1564865 1.63
AI548958hrasls 1.63
AB039828mup5 1.63
AA892888mettl7b 1.62
AI136882rgd1560784 1.60
NM_053999ppp2r2a 1.60
NM_058208socs2 1.60
NM_053977cdh17 1.58
NM_012608mme 1.57
BG375383rgd1308116 (nim1)1.55
BF414998rgd1306105 (tmem150c)1.54
AJ243338rt1-ce5 1.53
BF558981pcdh17 0.67
NM_031572cyp2c12 0.66
NM_130414abcg8 0.66
NM_012753cyp17a1 0.66
NM_033352abcd2 0.66
AA998516ccna2 0.66
U07202asns 0.65
BI281851loc685203 0.64
NM_012488a2m 0.64
NM_031050lum 0.64
NM_012521s100g 0.64
AA892854cxcl13 0.64
AF062389acsm2 0.63
BE112927cyfip2 0.63
AI101139tox 0.63
NM_019157aqp7 0.62
AI230228psat1 0.62
AI408151rgd1566215 0.60
AW252129nfe2 0.60
BE116152elovl6 0.59
BM390001rgd1562284 0.59
AF072816abcc3 0.58
BF396857elovl6 0.53
NM_053781akr1b7 0.40

3.4. Pathway Significance of Early Individual Development

The significant pathways were as follows: transport (obp3(AB039825), obp3(J00738), AB039826, AB039823, ust5r, mup5, AB039828, clca5, abcg8, abcd2, aqp7, and abcc3; ) and cell adhesion (cdh17, omd, jam3, pcdh17, ncam2, amigo1; ); steroid biosynthesis (obp3, hsd3b5, akr1c1, hsdl2, hsd17b6, hsd11b2, ar, and cyp17a1; P = 8.6e − 9), metabolic process (hsd3b5, dhrs7, hao2, mett17b, hsdl2, asns, acsm2, and psat1; ), oxidation reduction (hsd3b5, cyp2c13, cyp3a9, cyp2a2, hao2, akr1c1, cyp2c29, nox4, rgd1564865, hsdl2, me3, cyp2c12, cyp17a1, and akr1b7; ), and fatty acid biosynthesis (scd, fasn; ); transcription regulation (zfp37, zfp68, npas2, taf9b, ppargc1a, and nfe2; ) and regulation of cell cycle (ccng2, ccnb2, and ccna2; ); skeletal system development (col4a1, col5a2, col5a1, col1a2, and col1a1; P = 4.4e − 5) and organization (cav2, pex11a, onecut1, meox2, cml3, col5a2, and lox; ); immune response (rt1-ce5, cxcl9, rt1-aw2, tnfsf13, and cxcl13; ), signaling (ppp2r2a, socs2, olr59, rgs3, adora2b, cish, atp6ap2, pik3c3, ppp1r2, ghr, and nrg1; ), and proteolysis (mup5, mme, trhde, spink3, prcp, and rgd1562284; ) (Table 3).


Transportobp3, mup5, ust5r, mme, clca5, gpm6a, tmem163; abcg8, abcd2, aqp7, abcc3

Steroidobp3, hsd3b5, akr1c1, hsdl2, hsd17b6, hsd11b2, ar; cyp17a1

Metabolic processhsd3b5, dhrs7, hao2, mett17b, hsdl2; asns,acsm2,psat1

Redoxhsd3b5, cyp2c13, cyp3a9, cyp2a2, hao2, akr1c1, cyp2c29, nox4, rgd1564865, hsdl2, me3; cyp2c12, cyp17a1, akr1b7

Transcription regulationzfp37, zfp68, npas2; taf9b, ppargc1a, nfe2

Cell adhesioncdh17, omd, jam3; pcdh17, ncam2, amigo1

Collagen;col4a1, col5a2, col5a1, col1a2, col1a1

Immune responsert1-ce5, cxcl9, rt1-aw2, tnfsf13; cxcl13

Signalingppp2r2a, socs2, olr59, rgs3, adora2b, cish, atp6ap2, pik3c3, ppp1r2, ghr, nrg1;

Organizationcav2, pex11a, onecut1, meox2, cml3; col5a2,l ox,

Fatty acid biosynthesisscd, fasn;

Cyclinccng2; ccnb2, ccna2

Solute carrier (slc)41a2, 25a30, 9a3r1, 31a2; 13a3,1a3, 4a1,

Proteolysis (peptidase)mup5, mme, trhde, spink3, prcp; rgd1562284

Ubiquitinhspb1, usp18;

G proteingnai3 gnat3 adora2b;

Gene: higher; lower.

3.5. Genes Correlation Network of Early Individual Development

Furthermore, obp3, extracellular region and transporter, was correlated to membrane (ust5r, stac3, cdh17, mme, olr59, gpm6a, tmem163, abcg8, abcd2, and abcc3), adapter (stac3, socs2), transcription (zfp37, ccna2, asns, and rgd1562284), immune (rt1-ce5, rt1-aw2, cxcl13, and cyfip2), and redox (hsd3b5, cyp2c13, cyp2a2, dhrs7, hao2, akr1c1, nox4, inmt, dusp1, mettl7b, ppp2r2a, cyp17a1, and akr1b7) , ) (Figure 1, Supplementary Table 2).

3.6. qPCR Validation of Early Individual Development

qPCR validation for highlighted microarray genes was carried out for pups and adults. The results demonstrated that the mRNA level of obp3, a major regulator in odorant binding, was elevated 3.75-fold in the adult group compared to pups; the expression levels of rup2, hsd3b5, dhrs7, cyp2c13, ust5r, stac3, zfp37, ppp2r2a, socs2, atp6ap2, pik3c3, and ghr were elevated significantly in the adult rats compared to the pups, while the expression levels of pcdh17, abcg8, ccna2, s100 g, cxcl13, tox, and akr1b7 were decreased significantly (Figure 2(a), ).

3.7. Induction/Inhibition of obp3 and Its Targets

In order to characterize the interplay between opb3 and its potential targets, we evaluated the dexamethasone induction/cycloheximide inhibition of obp3 and coregulated genes of adults. Dexamethasone (0.1 μM) induced obp3 expression and upregulated its targets: hsd3b5, socs2, pik3c3, ppp2r2a (Figure 2(b)), and obp3 expression inhibition (0.05 μg/mL cycloheximide) downregulated hsd3b5, socs2, pik3c3, and cav2 (Figure 2(c)).

3.8. Obps and Its Related Proteins

In order to characterize opb3 protein and its related proteins, we assayed Western blotting. The expression levels of obp3, hsd3b5, ppp2r2a, socs2, and pik3c3 proteins were elevated significantly in the adult rats compared to the pups, while the expression levels of cxcl13, tox, and akr1b7 proteins were decreased significantly (Figure 2(d), ).

3.9. Metabolic Profile of Temporal Rats

Using PLS, invalid models indicated that adults were metabolically stationary from week 15 to week 19 of age (Table 4). With age (from week 8 to week 13 of age), taurine and octanoate (8 : 0) were increased, whilst succinate was lowered (, Figure 3).

(a) Cumulative comparison

Group, permutation test


Comparison with w8.
(b) Link and other comparisons






Control0.6770.919<0 0.6420.9300.7960.9200.734

Bold: invalid model. Components: autofit.

4. Discussions

Early development is a physiology process, and we found that in this early individual development, extracellular region and space (ECR)—SH2 containing protein—MAPK pathway plays a vital role. Meanwhile, early individual development is ECR and androgen-mediated feedforward coordination network of positive cancer-like growth and negative regulations.

4.1. Androgen-Responsive Genes

Androgen-dependent α2u globulin (obp3) is a group of low molecular weight (Mr ~18,000) male specific urinary proteins synthesized and secreted by hepatocytes. In the male rat, hepatic synthesis of α2u globulin begins at puberty (~40 days), reaches a peak level (~20 mg/day) at about 75 days, and declines during old age [21]. Age-dependent changes in the expression of androgen-responsive genes (alpha 2u globulin) reflect changing androgen sensitivity [2].

Meanwhile, cell cycle and mitosis gene mapre1 at week 16 was upregulated 1.25 times than at week 3 ().

Accordingly, androgen receptor at week 16 was upregulated 1.25 times than at week 3 ().

4.2. Development Network

Based on gene profiling, verification at mRNA, protein, and metabolite levels, we postulated that, in early development, extracellular region and space (ECR) obp3, rup2, pcdh17, a2m, and cxcl13 act as nutrition ligand and information input. Ligands interact with membrane transports ust5r, cdh17, mme, olr59, gpm6a, tmem163, abcg8, abcd2, abcc3, and SH2-containing/MAPK related signals stac3, socs2, cish/pik3c3, and nrg1 and regulate cell cycle, transcription, and proteolysis ccng2, ccnb2, ccna2/zfp37, zfp68, npas2, taf9b, ppargc1a, nfe2/hspb1, usp18, mup5, mme, trhde, spink3, and prcp, leading to short-term steroid, fatty acid biosynthesis, redox, and metabolic process obp3, hsd3b5, akr1c1, hsdl2, hsd17b6, hsd11b2, ar, cyp17a1/scd, fasn/cyp2c13, cyp3a9, cyp2a2, hao2, cyp2c29, nox4, me3, cyp2c12, akr1b7/dhrs7, mett17b, asns, acsm2, psat1 and long-term collagen development and organization col4a1, col5a2, col5a1, col1a2, col1a1/cav2, pex11a, onecut1, meox2, cml3, and lox. G protein coupled receptors/G protein olr59, rgs3 [22], adora2b/gnai3, gnat3, catalytic receptors socs2 [23], nim1 [24], atp6ap2, ghr and ECR signals converge at MAPK cascades (Figure 4). Protein expression to some extent confirmed key genes, for example, obp3, socs2, ppp2r2a, pik3c3, cxcl13, and hsd3b5 proteins dynamics (Figure 2).

4.3. Female-Prefer Genes

Female-specific tox changes in gene expression during postnatal liver development reflect the deceleration of liver growth and the induction of specialized liver functions, with widespread changes in sex-specific gene expression primarily occurring in male liver [25].

Male and female genes are both increased, but their magnitudes in male are larger than that in female-change fold of male gene obp3 is 3.75 times more at senior than at junior.

4.4. Development and Cancer

Hsd3b5 expression showed significant associations with the degree of hepatic steatosis [26], accompanied by increased testosterone with age (Table 1). Expression level of dehydrogenase/reductase member 7 (dhrs7) in rat regenerating liver was more than 968-fold compared to control [27]. Cdh17 [28], nim1 [24], scd, and fasn [29] were related to disease/cancer; upregulation of fasn was in accordance with elevated moderate-chain fatty acid octanoate (8 : 0). Thus, developmental process poses cancer-like characteristics.

Overlap between embryonic liver development and liver cancer is not only in cell cycle or apoptosis, but also in metabolic pathways associated with carbohydrate and lipid metabolism [30]. Fetal hepatocytes have high IGF2 and E2F3 expressions, and levels of IGF2 and E2F3 mRNA were positively correlated to human prostate and bladder cancers [31]. However, fetal and infant livers have no cancers.

4.5. Negative Control Genes

Socs2 [23], cdkn1a [32], rgs3 [22], cish, spink3, cyp17a1, and nfe2 [33] were involved in negative control. Cancer-like early individual development, but no cancer, is maybe due to counteracting effects of negative control and cooperation of the two sides.

4.6. Feedforward Regulation

Feedforward regulation in pheromone-activated MAPK pathway ensures stability and rapid reversibility of a cellular state [34].

Cxcl13, belonging to extracellular region [35], takes part in positive regulation of cytosolic calcium ion concentration and immune response [36].

Nonzero uterus dependent initial conditions allow fast early development and sensing, and meanwhile, feedforward modulations appear at reversible developmental transitions, because this network control can obtain the aims of growth stability and rapid reversibility without loss of external signaling information [34].

In a summary, qPCR validation was for gene expression profile, and meanwhile, cell induction/inhibition assays, Western blot, and NMR-based metabonomics were carried out for confirmation of gene results. Using dynamic assays of body weight, serum biochemistry, transcript, protein, and metabolite profile, we reveal that, in early individual development, increasing magnitude in male is larger than that in female, and cancer-like growth coordinates negative regulation; meanwhile, feedforward modulations appear at developmental transitions, obtaining aims of growth stability and rapid reversibility without superoxidation or maglinant growth; more importantly, extracellular matrix-kinase cascade responses play a vital role in this early individual development. Taken together, extracellular matrix-kinase cascade-based feedforward cooperation of cancer-like growth and negative regulation realize win-win long-term growth stability and short-term rapid reversibility/fluctuation in gradual transition of early individual development. This finding is particularly important for understanding the gene expression network of infant development.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Xiu-Ju Zhao conceived of the study, designed the analysis, coordinated the analyses and interpretation of results, and drafted the paper; Hexian Zhuo participated in the design of the study. All authors read, edited, and approved the final paper.


The authors would like to acknowledge KR Shockley. This work was supported in part by Natural Science Foundation of Hubei Province (2012FFB04802), Wuhan Polytechnic University (2012RZ06).

Supplementary Materials

Supplementary Table 1: Coexpressing genes between 16 weeks and 3 weeks old.

Supplementary Table 2: Correlation coefficients of genes network.

  1. Supplementary Tables


  1. A. K. Roy and B. Chatterjee, “Sexual dimorphism in the liver.,” Annual Review of Physiology, vol. 45, pp. 37–50, 1983. View at: Publisher Site | Google Scholar
  2. B. Chatterjee, G. Fernandes, B. P. Yu et al., “Calorie restriction delays age-dependent loss in androgen responsiveness of the rat liver,” FASEB Journal, vol. 3, no. 2, pp. 169–173, 1989. View at: Google Scholar
  3. B. T. Spear, L. Jin, S. Ramasamy, and A. Dobierzewska, “Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation,” Cellular and Molecular Life Sciences, vol. 63, no. 24, pp. 2922–2938, 2006. View at: Publisher Site | Google Scholar
  4. T. Li, J. Huang, Y. Jiang et al., “Multi-stage analysis of gene expression and transcription regulation in C57/B6 mouse liver development,” Genomics, vol. 93, no. 3, pp. 235–242, 2009. View at: Publisher Site | Google Scholar
  5. J. K. Dunnick, A. Brix, H. Cunny, M. Vallant, and K. R. Shockley, “Characterization of polybrominated diphenyl ether toxicity in wistar han rats and use of liver microarray data for predicting disease susceptibilities,” Toxicologic Pathology, vol. 40, no. 1, pp. 93–106, 2012. View at: Publisher Site | Google Scholar
  6. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at: Publisher Site | Google Scholar | Zentralblatt MATH
  7. J. D. Storey and R. Tibshirani, “Statistical significance for genomewide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9440–9445, 2003. View at: Publisher Site | Google Scholar | Zentralblatt MATH
  8. C.-A. Tsai, H.-M. Hsueh, and J. J. Chen, “Estimation of false discovery rates in multiple testing: application to gene microarray data,” Biometrics, vol. 59, no. 4, pp. 1071–1081, 2003. View at: Publisher Site | Google Scholar
  9. V. Todorov and P. Filzmoser, “Robust statistic for the one-way MANOVA,” Computational Statistics and Data Analysis, vol. 54, no. 1, pp. 37–48, 2010. View at: Publisher Site | Google Scholar | Zentralblatt MATH
  10. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, p. e45, 2001. View at: Publisher Site | Google Scholar
  11. W. P. Aue, E. Bartholdi, and R. R. Ernst, “Two-dimensional spectroscopy. Application to nuclear magnetic resonance,” The Journal of Chemical Physics, vol. 64, no. 5, pp. 2229–2246, 1976. View at: Publisher Site | Google Scholar
  12. W. P. Aue, J. Karhan, and R. R. Ernst, “Homonuclear broad band decoupling and two-dimensional J-resolved NMR spectroscopy,” Journal of Chemical Physics, vol. 64, no. 10, pp. 4226–4227, 1976. View at: Publisher Site | Google Scholar
  13. L. Braunschweiler and R. R. Ernst, “Coherence transfer by isotropic mixing: application to proton correlation spectroscopy,” Journal of Magnetic Resonance, vol. 53, no. 3, pp. 521–528, 1983. View at: Publisher Site | Google Scholar
  14. X.-J. Zhao, C. Huang, H. Lei, X. Nie, H. Tang, and Y. Wang, “Dynamic metabolic response of mice to acute mequindox exposure,” Journal of Proteome Research, vol. 10, no. 11, pp. 5183–5190, 2011. View at: Publisher Site | Google Scholar
  15. J. Trygg and S. Wold, “Orthogonal projections to latent structures (O-PLS),” Journal of Chemometrics, vol. 16, no. 3, pp. 119–128, 2002. View at: Publisher Site | Google Scholar
  16. C. Henegar, K. Clement, and J. Zucker, “Unsupervised multiple-instance learning for functional profiling of genomic data,” in Proceedings of the European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases, pp. 186–197, 2006. View at: Google Scholar
  17. R. Opgen-Rhein and K. Strimmer, “From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression data,” BMC Systems Biology, vol. 1, article 37, 2007. View at: Publisher Site | Google Scholar
  18. T. Hastie, R. Tibshirani, and J. Friedman, The Elements of Statical Learning, Springer, New York, NY, USA, 2nd edition, 2008.
  19. F. Lindgren, B. Hansen, W. Karcher, M. Sjöström, and L. Eriksson, “Model validation by permutation tests: applications to variable selection,” Journal of Chemometrics, vol. 10, no. 5-6, pp. 521–532, 1996. View at: Google Scholar
  20. E. Axelsson, A. Ratnakumar, M.-L. Arendt et al., “The genomic signature of dog domestication reveals adaptation to a starch-rich diet,” Nature, vol. 495, no. 7441, pp. 360–364, 2013. View at: Publisher Site | Google Scholar
  21. A. K. Roy, B. Chatterjee, K. V. S. Rao, C. V. R. Murty, F. H. Sarkar, and D. Majumdar, “Androgenic regulation of hepatic gene expression,” The Journal of Steroid Biochemistry, vol. 27, no. 4–6, pp. 1129–1134, 1987. View at: Publisher Site | Google Scholar
  22. Q. Wang, M. Liu, B. Mullah, D. P. Siderovski, and R. R. Neubig, “Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 24949–24958, 2002. View at: Publisher Site | Google Scholar
  23. B. R. Dey, S. L. Spence, P. Nissley, and R. W. Furlanetto, “Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor,” The Journal of Biological Chemistry, vol. 273, no. 37, pp. 24095–24101, 1998. View at: Publisher Site | Google Scholar
  24. T. M. P. Team, “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC),” Genome Research, vol. 14, pp. 2121–2127, 2004. View at: Google Scholar
  25. T. Conforto and D. Waxman, “Sex-specific mouse liver gene expression: genome-wide analysis of developmental changes from pre-pubertal period to young adulthood,” Biology of Sex Differences, vol. 3, p. 9, 2012. View at: Publisher Site | Google Scholar
  26. N. Guillén, M. A. Navarro, C. Arnal et al., “Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver,” Physiological Genomics, vol. 37, no. 3, pp. 187–198, 2009. View at: Publisher Site | Google Scholar
  27. W.-B. Wang, J.-M. Fan, X.-L. Zhang, J. Xu, and W. Yao, “Serial expression analysis of liver regeneration-related genes in rat regenerating liver,” Molecular Biotechnology, vol. 43, no. 3, pp. 221–231, 2009. View at: Publisher Site | Google Scholar
  28. J. Wang, W.-M. Kang, J.-C. Yu, Y.-Q. Liu, Q.-B. Meng, and Z.-J. Cao, “Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway,” Cancer Biology and Therapy, vol. 14, no. 3, pp. 262–270, 2013. View at: Publisher Site | Google Scholar
  29. S. B. Biddinger, K. Almind, M. Miyazaki, E. Kokkotou, J. M. Ntambi, and C. R. Kahn, “Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome,” Diabetes, vol. 54, no. 5, pp. 1314–1323, 2005. View at: Publisher Site | Google Scholar
  30. D. Becker, I. Sfakianakis, M. Krupp et al., “Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC,” Molecular Cancer, vol. 11, article 55, 2012. View at: Publisher Site | Google Scholar
  31. J. C. Lui and J. Baron, “Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 15, pp. 6181–6186, 2013. View at: Publisher Site | Google Scholar
  32. F. C. C. Rodrigues, R. S. Kawasaki-Oyama, J. F. G. Fo et al., “Analysis of CDKN1A polymorphisms: markers of cancer susceptibility?” Cancer Genetics and Cytogenetics, vol. 142, no. 2, pp. 92–98, 2003. View at: Publisher Site | Google Scholar
  33. J. Wang, K. Huo, L. Ma et al., “Toward an understanding of the protein interaction network of the human liver,” Molecular Systems Biology, vol. 7, article 536, 2011. View at: Publisher Site | Google Scholar
  34. A. Doncic and J. M. Skotheim, “Feedforward regulation ensures stability and rapid reversibility of a cellular state,” Molecular Cell, vol. 50, no. 6, pp. 856–868, 2013. View at: Publisher Site | Google Scholar
  35. T. A. Rupprecht, C. J. Kirschning, B. Popp et al., “Borrelia garinii induces CXCL13 production in human monocytes through toll-like receptor 2,” Infection and Immunity, vol. 75, no. 9, pp. 4351–4356, 2007. View at: Publisher Site | Google Scholar
  36. C.-H. Jenh, M. A. Cox, W. Hipkin et al., “Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor,” Cytokine, vol. 15, no. 3, pp. 113–121, 2001. View at: Publisher Site | Google Scholar

Copyright © 2014 Xiu-Ju Zhao and Hexian Zhuo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.